Evidence map›Paper›PMID 26885274›Full record

ArticleAmerican journal of translational research2015

miR-451 regulates FoxO3 nuclear accumulation through Ywhaz in human colorectal cancer.

Yaoyao Li, Jijun Wang, Xiaorong Dai, Zhengbin Zhou, Jing Liu, Yu Zhang, Yan Li, Yaying Hou, Lei Pang, Xiaohong Wang and 6 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Unraveling the therapeutic landscape of miRNAs in pancreatic cancer.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Yaoyao LiNon-Coding RNA Center, Medical College of Yangzhou UniversityYangzhou, Jiangsu 225001, China; Department of Gastroenterology, Taixing People's Hospital Affiliated to Yangzhou UniversityTaixing, Jiangsu 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Medical College of Yangzhou UniversityYangzhou, Jiangsu 225001, China.
Jijun WangNon-Coding RNA Center, Medical College of Yangzhou University Yangzhou, Jiangsu 225001, China.
Xiaorong DaiDepartment of Gastroenterology, Taixing People's Hospital Affiliated to Yangzhou University Taixing, Jiangsu 225001, China.
Zhengbin ZhouDepartment of Gastroenterology, Taixing People's Hospital Affiliated to Yangzhou University Taixing, Jiangsu 225001, China.
Jing LiuDepartment of Gastroenterology, Taixing People's Hospital Affiliated to Yangzhou University Taixing, Jiangsu 225001, China.
Yu ZhangNon-Coding RNA Center, Medical College of Yangzhou University Yangzhou, Jiangsu 225001, China.
Yan LiNon-Coding RNA Center, Medical College of Yangzhou University Yangzhou, Jiangsu 225001, China.
Yaying HouNon-Coding RNA Center, Medical College of Yangzhou University Yangzhou, Jiangsu 225001, China.
Lei PangNon-Coding RNA Center, Medical College of Yangzhou University Yangzhou, Jiangsu 225001, China.
Xiaohong WangNon-Coding RNA Center, Medical College of Yangzhou University Yangzhou, Jiangsu 225001, China.
Chenhai WangNon-Coding RNA Center, Medical College of Yangzhou University Yangzhou, Jiangsu 225001, China.
Zhenfeng HaoDepartment of Gastroenterology, Taixing People's Hospital Affiliated to Yangzhou University Taixing, Jiangsu 225001, China.
Yanqing ZhangNon-Coding RNA Center, Medical College of Yangzhou University Yangzhou, Jiangsu 225001, China.
Jixin JiangDepartment of Pathology, Subei People's Hospital of Jiangsu Province Affiliated to Yangzhou University Yangzhou 225001, China.
Hongwei ChengDepartment of Gastroenterology, Taixing People's Hospital Affiliated to Yangzhou University Taixing, Jiangsu 225001, China.
Duonan YuNon-Coding RNA Center, Medical College of Yangzhou UniversityYangzhou, Jiangsu 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Medical College of Yangzhou UniversityYangzhou, Jiangsu 225001, China; Institute of Comparative Medicine, Yangzhou UniversityYangzhou 225001, China.
Yangzhou University · CNTaixing People's Hospital · CNNorthern Jiangsu People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveOur previous studies reported that miR-451 could protect against erythroid oxidant stress target gene-Ywhaz (14-3-3zeta) via inhibiting FoxO3 in the erythropoiesis. This study aimed to investigate the potential mechanism underlying the regulatory effect of miR-451 on human colorectal cancer (CRC) cells.

methodsIn this study, expressions of miR-451 and Ywhaz in CRC tissues and adjacent normal tissues were detected by quantitative real-time PCR (qRT-PCR) and immunohistochemistry respectively. Human colon cancer cell lines were transfected with miR-451-MSCV-PIG retroviral vector to restore miR-451 expression. Ywhaz-3'UTR luciferase reporter assay confirmed Ywhaz as a direct target gene of miR-451. HCT116 cells and H29 cells were transfected with -shRNA-Ywhaz (pSGU6-Ywahz-shRNA-GFP) and the protein level of FoxO3 in the nucleus and cytoplasm was detected via Western blot assay. The anti-tumor effects of miR-451 were further verified in nude mice.

resultsmiR-451 was significantly down-regulated in human colon cancer tissues and cell lines (HCT116 and HT29), and inversely correlated with Dukes stage of colon cancer. Ywhaz was a candidate target gene of miR-451 and able to stimulate tumor growth via binding to FoxO3, inhibiting the FoxO3 nuclear accumulation.

conclusionmiR-451 may inhibit the colon cancer growth in vitro and in vivo, likely through directly targeting Ywhaz and indirectly regulating the nuclear accumulation of FoxO3.

Indexed as

Colorectal cancerFoxO3microRNA-451Ywhaz (14-3-3zeta)

Identifiers

PMID26885274
PMCPMC4731674
OpenAlexW2410558918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.